Efficacy and Safety of Eculizumab in Kidney Transplant Patients With Primary Atypical Hemolytic-Uremic Syndrome. Gonzalez CC, Lopez-Jimenez V, Vazquez-Sanchez T, Vazquez-Sanchez E, et al. Transplant Proc 2021 Dec 11. pii: S0041-1345(21)00815.

Read + Share

Amedeo Smart

Independent Medical Education

Gonzalez CC, Lopez-Jimenez V, Vazquez-Sanchez T, Vazquez-Sanchez E, et al. Efficacy and Safety of Eculizumab in Kidney Transplant Patients With Primary Atypical Hemolytic-Uremic Syndrome. Transplant Proc 2021 Dec 11. pii: S0041-1345(21)00815.
PMID: 34906374